Trial Search Results
Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing
The goal of this study is to identify genetic changes associated with the initiation, progression, and treatment response of response of cutaneous and hematologic disorders using recently developed high-throughput sequencing technologies. The improved understanding of the genetic changes associated with cutaneous and hematologic disorders may lead to improved diagnostic, prognostic and therapeutic options for these disorders.
Stanford is currently not accepting patients for this trial.
- 18 years of age or older
- Patient meets the clinical and/or pathologic criteria for the cutaneous or hematologic
disorder being examined.
- Patient is willing to provide skin biopsies and five 10 mL tubes of peripheral blood.
- Less than 18 years of age
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study